KMKenneth A. Mayuga

Kenneth A. Mayuga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kenneth A. Mayuga has a total of 107 co-authors. Here are the top co-authors by number of shared publications:

  • Erik H. Van Iterson

    Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, 9500 Euclid Avenue, J2-2, Cleveland, OH, 44195, USA

    4 shared publications
  • Haitham M. Ahmed

    Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA

    3 shared publications
  • Ramya Vajapey

    Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA

    3 shared publications
  • Erika Hutt Centeno

    Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic, 9500 Euclid Avenue, J2-2, Cleveland, OH, 44195, USA

    2 shared publications
  • Jeffrey J. Goldberger

    Division of Cardiology, University of Miami, Miami, USA

    2 shared publications
  • Mina K. Chung

    Heart, Vascular and Thoracic Institute, and Cleveland Clinic Research, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, OH (M.K.C.).

    2 shared publications

Latest Publications

  • Open Access

    Presumed Postural Tachycardia Syndrome

    by Diego Ramonfaur, Iqbal El-Assaad, Kenneth A. Mayuga

  • Open Access

    Anticoagulants for the prevention and treatment of venous thromboembolism in humans exposed to microgravity: A hybrid systematic and narrative review

    by Adele Watfa, Arwa Younis, Andrew Winnard-Brewer, Katie M. Greenlee, Julia Ferrin, Niraj Varma, Jerry G. Myers, Virginia Wotring, Kenneth A. Mayuga

  • Open Access

    Intracardiac echocardiography guided anatomical approach to cardioneuroablation: feasibility and outcomes

    by Medhat Farwati, Ayman A Hussein, Santiago Giraldo, William Bautista, Koji Higuchi, Bryan Baranowski, Mandeep Bhargava, Thomas D Callahan, Mina K Chung, Roy Chung, et al.

    Aims: Anatomical studies have documented a close topographical relationship between the ganglionated plexi (GP) containing parasympathetic inputs to the sinus node (SN) and atrioventricular node (AVN) and the epicardial fat pads (FPs) within the Waterston’s interatrial groove. We aimed to investigate the feasibility and outcomes of a novel anatomical approach to cardioneuroablation (CNA) that targets the atrial areas adjacent to the interatrial FPs identified with intracardiac echocardiography (ICE). Methods and results: About 17 patients [37.3 ± 10.2 years, 47% female] undergoing CNA for recurrent vasovagal syncope and documented sinus pauses (n = 13, 76%) and/or AVN block (AVB, n = 4, 16%) were included. The right superior RS-FP containing the RS-GP (target for SN vagal denervation) and the right inferior RI-FP containing the RI-GP (target for AVN vagal denervation) were identified with ICE and reconstructed on a 3D electroanatomic map. At baseline, all patients had provocable sinus pauses/AVB with extracardiac high-frequency vagal stimulation (ECVS). The target FPs could be identified in all patients and were adjacent to septal LA and RA sites covering an average surface area of 3.7 ± 1.4 cm2 and 2.97 ± 1.21 cm2, respectively. A total of 33 ± 15 RF ablations (30–40W, 60 s) were delivered to cover the target LA/RA area. A > 25% shortening of the PP interval was observed within the first 1–2 RF lesions in all cases. After ablation, complete abolition of sinus pauses/AVB response with ECVS was achieved in all patients, and 2 mg of atropine infusion resulted in no PP/PR interval change. After a median follow-up of 12 months (range 4–25 months), 16 patients (94%) remained free of recurrent symptoms (1 patient underwent repeat CNA for recurrent pre-syncope and AVB, 1 patient underwent PPM implant following ECG recording of asymptomatic diurnal AVB). Conclusion: An ICE-guided anatomical approach to CNA targeting visible FPs at the Waterston’s groove is a feasible and effective strategy to achieve SN/AVN vagal denervation, with good outcomes at mid-term follow-up.


  • Chronobiologic Analysis of Electrical Storm at a Single Tertiary Care Center

    by Cameron Incognito, Becky Yi-Wen Liao, Jeffrey Hedley, Joshua Parker, Kristine T. Posadas, Oussama Wazni, Kenneth Mayuga, Venu Menon, John Rickard, W.H. Tang, et al.

  • Open Access

    Skin Biopsy and Quantitative Sudomotor Axon Reflex Testing in Patients With Postural Orthostatic Tachycardia Syndrome

    by Ryan Zhang, Ken Mayuga, Robert Shields, Christopher Cantrell, Robert Wilson

    Purpose: No formal diagnostic criteria exist for the neuropathic subtype of postural orthostatic tachycardia syndrome (POTS). Skin biopsy and quantitative sudomotor axon reflex testing (QSORT) are preferred methods of assessment for autonomic small fiber neuropathy (SFN). This study characterizes the utility of these testing methods at a tertiary center and identifies clinical features associated with abnormal testing. Methods: Medical records of 2658 patients undergoing tilt table testing at a single institution between June 2018 and December 2020 were reviewed. Patients with postural orthostatic tachycardia syndrome were included for analysis of intraepidermal nerve fiber density (IENFD), sweat output, comorbidities, symptoms, measures of cardiovascular autonomic function, and serum antibody levels. Results: 356 patients (90% female, mean age 31 ± 10) met the diagnostic criteria for postural orthostatic tachycardia syndrome. Of 211 patients who underwent quantitative sudomotor axon reflex testing, 70 (33%) demonstrated reduced sweat output. These patients were more likely to demonstrate sympathetic impairment during the Valsalva maneuver. Of 80 patients who underwent skin biopsies, 19 (24%) demonstrated reduced intraepidermal nerve fiber density. These patients tended to be older and have reduced heart rate variability during deep breathing. Neither test was associated with specific serum antibodies, symptoms, or comorbidities, though there was a trend toward higher rates of comorbid autoimmune disease in patients with abnormal testing. Conclusion: A subset of patients with postural orthostatic tachycardia syndrome have evidence of small fiber neuropathy. These patients tend to have impaired cardiovascular autonomic function but are otherwise similar to patients with no evidence of small fiber neuropathy.


  • Sinus Tachycardia: a Multidisciplinary Expert Focused Review

    by Kenneth A. Mayuga, Artur Fedorowski, Fabrizio Ricci, Rakesh Gopinathannair, Jonathan Walter Dukes, Christopher Gibbons, Peter Hanna, Dan Sorajja, Mina Chung, David Benditt, et al.

    Sinus tachycardia (ST) is ubiquitous, but its presence outside of normal physiological triggers in otherwise healthy individuals remains a commonly encountered phenomenon in medical practice. In many cases, ST can be readily explained by a current medical condition that precipitates an increase in the sinus rate, but ST at rest without physiological triggers may also represent a spectrum of normal. In other cases, ST may not have an easily explainable cause but may represent serious underlying pathology and can be associated with intolerable symptoms. The classification of ST, consideration of possible etiologies, as well as the decisions of when and how to intervene can be difficult. ST can be classified as secondary to a specific, usually treatable, medical condition (eg, pulmonary embolism, anemia, infection, or hyperthyroidism) or be related to several incompletely defined conditions (eg, inappropriate ST, postural tachycardia syndrome, mast cell disorder, or post-COVID syndrome). While cardiologists and cardiac electrophysiologists often evaluate patients with symptoms associated with persistent or paroxysmal ST, an optimal approach remains uncertain. Due to the many possible conditions associated with ST, and an overlap in medical specialists who see these patients, the inclusion of experts in different fields is essential for a more comprehensive understanding. This article is unique in that it was composed by international experts in Neurology, Psychology, Autonomic Medicine, Allergy and Immunology, Exercise Physiology, Pulmonology and Critical Care Medicine, Endocrinology, Cardiology, and Cardiac Electrophysiology in the hope that it will facilitate a more complete understanding and thereby result in the better care of patients with ST.


  • Open Access

    COVID-19 and postural tachycardia syndrome: a case series

    by William H Parker, Rohit Moudgil, Robert G Wilson, Adriano R Tonelli, Kenneth A Mayuga, Tamanna K Singh

    Background: Postural tachycardia syndrome (PTS) is a novel identified sequela of COVID-19 infection. This observational study describes clinical presentation, testing, and treatment response in seven patients diagnosed with PTS following COVID-19 infection. Case summary: A total of seven active patients (three collegiate athletes, one recreational athlete, two registered nurses, one hospitality employee), age 24 ± 6 years, and six females were followed for a mean of 152 ± 105 days after contracting COVID-19. Tilt table was performed to establish the diagnosis. The most common presenting symptoms were palpitations (7/7), dyspnoea (6/7), and gastrointestinal complaints (5/7). One patient required hospitalization for symptom management. The mean latency of PTS onset following COVID-19 was 21 ± 15 days. Electrocardiograms (ECGs) demonstrated sinus rhythm in all patients, one with resting sinus tachycardia. Echocardiogram demonstrated normal systolic and diastolic left ventricular function in all patients. On tilt table testing, baseline heart rate (HR) was 72 ± 12 with maximum HR reaching 136 ± 13. Six of seven patients failed to respond to supportive therapy alone, and two patients failed medical management with ivabradine, midodrine, and/or metoprolol. Of three severely symptomatic patients, two demonstrated some degree of clinical recovery with intravenous immunoglobulin (IVIG). Discussion: This novel case series describes the development of PTS in the context of COVID-19 infection. Severity of symptoms and response to treatment was heterogeneous. Interestingly, patients were poorly responsive to traditional PTS treatments, but IVIG showed potential as a possible therapeutic strategy for refractory PTS in two patients, particularly following COVID-19 infection.


  • Open Access

    Functional capacity and quality of life in the postural tachycardia syndrome: A retrospective cross-sectional study

    by Erika Hutt, Ramya Vajapey, Erik H. Van Iterson, Fredrick Jaeger, Leslie Cho, Haitham M. Ahmed, Kenneth A. Mayuga

    Postural tachycardia syndrome (POTS) is a complex syndrome of orthostatic intolerance that significantly affects quality of life. The relationship between functional capacity, quality of life, and age remains poorly understood in this patient population. The purpose of this cross-sectional study was to assess the clinical and exercise characteristics of patients with POTS who underwent exercise stress testing as part of cardiac rehabilitation, and to evaluate the relationships between functional capacity with age and sex, as well as the relationship between functional capacity and quality of life. We included 255 consecutive adult patients with the diagnosis of POTS, by tilt table testing, who underwent exercise stress testing between 2012 and 2017. Clinical and stress test data were obtained from electronic medical records. Of the 255 patients, 232 (91%) were women, with median age 33.5 years. Prevalence of traditional CAD risk factors was low (2% diabetes, 13% hypertension, 7% hyperlipidemia, and 26% smoking history). Mean resting BP was 114 ± 13 mmHg systolic, resting HR was 76 ± 13 bpm, METs achieved 9.2 ± 2.2, and 1 min HR recovery 32 ± 17 bpm. 113 patients (44%) had abnormal functional capacity for age and sex. When analyzed by age groups, younger POTS patients had increasingly lower than expected functional capacity (compared to predicted normals) than did older patients (ANOVA P = 0.0017). The SF-36 physical component of patients with abnormal functional capacity was significantly lower than those with normal functional capacity. (p = 0.006). In this large cohort, patients with POTS were predominantly female (91%) and relatively young. The novel findings are that younger patients with POTS were more likely to have lower-than-average functional capacity for their age and sex compared to older patients, and that abnormal functional capacity was associated with lower quality of life by SF-36 physical component.


  • Should I evaluate my patient with atrial fibrillation for sleep apnea?

    by Mirna B. Ayache, Reena Mehra, Kenneth A. Mayuga

    Yes. The prevalence of sleep apnea is high in patients with atrial fibrillation, and vice versa.


  • Correction to: ST‑segment changes during tilt table testing for postural tachycardia syndrome: correlation with exercise stress test results

    by Ramya Vajapey, Erika Hutt Centeno, Erik H. Van Iterson, Haitham M. Ahmed, Kenneth A. Mayuga

    Unfortunately, the 3rd author name was incorrectly published in the original publication. The complete correct name is given below.